259 related articles for article (PubMed ID: 8277193)
1. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.
Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB
J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193
[No Abstract] [Full Text] [Related]
2. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
[No Abstract] [Full Text] [Related]
3. Cholera vaccines.
Ryan ET; Calderwood SB
Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
[TBL] [Abstract][Full Text] [Related]
4. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Islam K; Hossain M; Kelly M; Mayo Smith LM; Charles RC; Bhuiyan TR; Kováč P; Xu P; LaRocque RC; Calderwood SB; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006376. PubMed ID: 29624592
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
[TBL] [Abstract][Full Text] [Related]
7. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
8. Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity.
Zamri HF; Shamsudin MN; Rahim RA; Neela V
Vaccine; 2012 May; 30(21):3231-8. PubMed ID: 22426330
[TBL] [Abstract][Full Text] [Related]
9. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
[TBL] [Abstract][Full Text] [Related]
11. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
12. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
[TBL] [Abstract][Full Text] [Related]
13. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
14. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Kaper JB; Levine MM
J Infect Dis; 1992 Oct; 166(4):837-41. PubMed ID: 1527420
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.
Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK
PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.
Xian TH; Sinniah K; Yean CY; Krishnamoorthy V; Bahari MB; Ravichandran M; Prabhakaran G
BMC Immunol; 2020 May; 21(1):29. PubMed ID: 32450807
[TBL] [Abstract][Full Text] [Related]
17. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
18. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
Kaper JB; Levine MM
Res Microbiol; 1990; 141(7-8):901-6. PubMed ID: 2101480
[TBL] [Abstract][Full Text] [Related]
19. Live oral vaccines against cholera: an update.
Levine MM; Kaper JB
Vaccine; 1993; 11(2):207-12. PubMed ID: 8438619
[TBL] [Abstract][Full Text] [Related]
20. Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine.
Murugaiah C; Nik Mohd Noor NZ; Mustafa S; Manickam R; Pattabhiraman L
PLoS One; 2014; 9(2):e81817. PubMed ID: 24505241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
